SV Health Investors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,719,576
| Closed | -$25.7M | – | 10 |
|
|
2020
Q4 | $25.7M | Hold |
1,719,576
| – | – | 12.37% | 4 |
|
|
2020
Q3 | $21.7M | Hold |
1,719,576
| – | – | 10.97% | 4 |
|
|
2020
Q2 | $20.8M | Hold |
1,719,576
| – | – | 14.43% | 5 |
|
|
2020
Q1 | $13.2M | Hold |
1,719,576
| – | – | 11.03% | 6 |
|
|
2019
Q4 | $30.6M | Hold |
1,719,576
| – | – | 18.55% | 2 |
|
|
2019
Q3 | $19.9M | Hold |
1,719,576
| – | – | 14.01% | 4 |
|
|
2019
Q2 | $38.1M | Sell |
1,719,576
-111,972
| -6% | -$2.48M | 25.57% | 1 |
|
|
2019
Q1 | $52.4M | Sell |
1,831,548
-716,654
| -28% | -$20.5M | 30.75% | 1 |
|
|
2018
Q4 | $50.3M | Sell |
2,548,202
-31,288
| -1% | -$618K | 30.98% | 1 |
|
|
2018
Q3 | $57M | Hold |
2,579,490
| – | – | 16.7% | 3 |
|
|
2018
Q2 | $20.9M | Hold |
2,579,490
| – | – | 9.62% | 4 |
|
|
2018
Q1 | $24.5M | Hold |
2,579,490
| – | – | 18.34% | 3 |
|
|
2017
Q4 | $25.2M | Hold |
2,579,490
| – | – | 13.28% | 3 |
|
|
2017
Q3 | $17.4M | Hold |
2,579,490
| – | – | 13.16% | 3 |
|
|
2017
Q2 | $19M | Hold |
2,579,490
| – | – | 20.43% | 2 |
|
|
2017
Q1 | $20.1M | Hold |
2,579,490
| – | – | 22.25% | 2 |
|
|
2016
Q4 | $18.2M | Buy |
+2,579,490
| New | +$18.2M | 15.36% | 2 |
|